Clinical Trial Update: ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the distribution of indocyanine green (ICG) in benign and malignant breast tissue using near-infrared fluorescence imaging…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Breast Cancer. | Phase 1, Phase 2 | Status: COMPLETED